| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 07/19/2000 | EP1019434A2 Inhibitors of metalloproteinases, their therapeutic use, and process for the production of the starting compound in their synthesis |
| 07/19/2000 | EP1019432A1 The ob receptor and methods of diagnosing and treating weight |
| 07/19/2000 | EP1019430A2 Automatable method for preparing samples which can be universally applied |
| 07/19/2000 | EP1019424A2 Reagent and method for attaching target molecules to a surface |
| 07/19/2000 | EP1019423A2 Method for producing a pentopyranosyl nucleoside |
| 07/19/2000 | EP1019420A1 Methods for the production of platinum-based linkers between labels and bio-organic molecules, for labelling bio-organic molecules, for detecting biological substances of interest and diagnostic test kits |
| 07/19/2000 | EP1019390A4 1,2 chemiluminescent dioxetanes of improved performance |
| 07/19/2000 | EP1019390A1 1,2 chemiluminescent dioxetanes of improved performance |
| 07/19/2000 | EP1019379A1 Peroxide-based chemiluminescent assays and chemiluminescent compounds used therein |
| 07/19/2000 | EP1019360A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 07/19/2000 | EP1019193A2 Diagnostic devices and apparatus for the controlled movement of reagents without membranes |
| 07/19/2000 | EP1019092A1 Therapeutic and diagnostic tools for impaired glucose tolerance conditions |
| 07/19/2000 | EP1019091A1 50 human secreted proteins |
| 07/19/2000 | EP1019086A1 Altered dna synthesome components as biomarkers for malignancy |
| 07/19/2000 | EP1019080A2 Modulation of lerk-2-mediated cell adhesion |
| 07/19/2000 | EP1019075A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 07/19/2000 | EP1019072A1 Method for assisting in differential diagnosis and treatment of autistic syndromes |
| 07/19/2000 | EP1019069A2 Novel methods for testing inhibitors of paired helical filaments and uses for treatment of alzheimer's disease |
| 07/19/2000 | EP1019061A1 Urease-responsive delivery systems for diagnostic and therapeutic applications |
| 07/19/2000 | EP1019028A1 $i(CHLAMYDIA) PROTEIN, GENE SEQUENCE AND USES THEREOF |
| 07/19/2000 | EP1018938A2 Breath test analyser |
| 07/19/2000 | EP1017498A4 Multi-well plate |
| 07/19/2000 | EP0856155A4 Fluorescent and luminescent labelling compositions and methods for their use |
| 07/19/2000 | EP0821551A4 Screening assay for the identification of inhibitors of macrophage migration inhibitory factor |
| 07/19/2000 | EP0804121A4 Breathable liquid elimination analysis |
| 07/19/2000 | EP0679091B1 Chemotactic factors for human spermatozoa and their use in human assisted fertilization |
| 07/19/2000 | EP0527815B1 Hepatitis c virus epitopes |
| 07/19/2000 | CN1260878A Method and industrial process for determining dose-level characteristics of multiple unit system |
| 07/19/2000 | CN1260833A LAG-3 splice variants |
| 07/19/2000 | CN1260785A Method for producing quinazoline-diones in solid phase and use of the same |
| 07/19/2000 | CN1260492A Tumor prognosis evaluation reagent kit and its preparation technology |
| 07/19/2000 | CN1260491A Immunologic combined detection reagent kit and its preparation technology |
| 07/19/2000 | CN1260490A Semi-quantitative one-step immunologic diagnosis method |
| 07/19/2000 | CN1260489A Formulation for hematometer diluent reagent and its making technology |
| 07/19/2000 | CN1260488A Formulation for hematometer hemolysin reagent and its making technology |
| 07/19/2000 | CN1054609C Monoclonal antibody of human combining mosaic for recognizing epidermal growth factor receptor |
| 07/18/2000 | US6091976 Determination of glucose concentration in tissue |
| 07/18/2000 | US6091484 Oil quantity and quality indicator |
| 07/18/2000 | US6091004 Gene encoding a protein involved in the signal transduction cascade leading to systemic acquired resistance in plants |
| 07/18/2000 | US6090938 Detection of modulators of gene expression: for measurement of glucans in fluids; for treatment of infections, inflammation, autoimmune diseases, ischemia, cancer, and asthma; anticarcinogenic agents; antiischemic agents |
| 07/18/2000 | US6090936 Device for isolating nucleic acids |
| 07/18/2000 | US6090929 Polynucleotide coding a cyclic adenosine monophosphate-dependent kinase binding polypeptide; for recombinant production of the kinase binding domain polypeptides; for treatment of myasthenia gravis |
| 07/18/2000 | US6090925 Macromolecular microparticles and methods of production and use |
| 07/18/2000 | US6090923 Immunoglobulin that preferentially binds a human cytotoxin; for the treatment of virus infected or tumor target cells |
| 07/18/2000 | US6090920 Aminoterminal propeptides of typed 1 procollagen |
| 07/18/2000 | US6090918 Polypeptide associated with the inhibition of prostaglandin biosynthesis and treating inflammation |
| 07/18/2000 | US6090912 Multiplicity of separate solid supports with surface having suceptible linker to single species of test compound and with interior having attached non-cleavable coding molecule; for screening ligands or acceptors |
| 07/18/2000 | US6090778 Neurturin and related growth factors |
| 07/18/2000 | US6090631 Methods and compositions for screening for presynaptic calcium channel blockers |
| 07/18/2000 | US6090623 Nucleotide sequences which code receptors associated with ionic mobility; for the detection of genetic defects associated with ionic mobility; for detection of modulators of ionic mobility |
| 07/18/2000 | US6090622 Human embryonic pluripotent germ cells |
| 07/18/2000 | US6090591 Selective amplification of target polynucleotide sequences |
| 07/18/2000 | US6090579 Human SDR2 cDNA clone |
| 07/18/2000 | US6090578 Composition comprising at least 75% w/w of human multiple tumor suppressor 1 polypeptide; diagnosis of predisposition for cancer; anticarcinogenic agents; gene therapy |
| 07/18/2000 | US6090576 Nucleotide and amino acid sequences; for diagnosis of infections, immunogens, and vaccines especially against otitis media |
| 07/18/2000 | US6090573 Two step process |
| 07/18/2000 | US6090572 Using simple, disposable device to provide clarified liquid for further analysis or disposal; liquid is expressed from device by squeezing pliant body |
| 07/18/2000 | US6090571 Compounds, compositions and methods for generating chemiluminescence with phosphatase enzymes |
| 07/18/2000 | US6090570 Mixing sample with reagent having a lower content of functional factor v than normal, human plasma; adding factor v activator; adding reagent which degrades factor va; and determining activation of prothrombin to form thrombin |
| 07/18/2000 | US6090569 Selection of livestock using IGF levels |
| 07/18/2000 | US6090568 Format for minimizing interferences in chemiluminescent thin-film immunoassays |
| 07/18/2000 | US6090567 Homogeneous immunoassays using mutant glucose-6-phosphate dehydrogenases |
| 07/18/2000 | US6090566 Diagnostic method detecting loss of wild-type p53 |
| 07/18/2000 | US6090565 Measuring level of at least one glucosylceramide in said test cell and comparing to level in non-drug resistant cell; higher level indicates resistance |
| 07/18/2000 | US6090564 Amino acid sequence of human small nuclear ribonucleoprotein protein; for diagnosis, prevention and treatment of systemic lupus erythematosus |
| 07/18/2000 | US6090552 Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon |
| 07/18/2000 | US6090545 Multi-array, multi-specific electrochemiluminescence testing |
| 07/18/2000 | US6090543 Cleavage of nucleic acids |
| 07/18/2000 | US6090540 Methods for judging the possibility of the onset of bovine leukemia and the resistance thereto |
| 07/18/2000 | US6090539 Screening for a bioactive agent by adding candidate library to samples and determining binding to rad51, a protein involved in homologous recombination |
| 07/18/2000 | US6090408 Crosslinked lipids; in situ detection |
| 07/18/2000 | US6090387 Vaccination and methods against diseases resulting from pathogenic responses |
| 07/18/2000 | US6090382 Human antibodies that bind human TNFα |
| 07/18/2000 | US6090366 Process for the preparation of an organ specific antibodies labeled with technetium-99m |
| 07/18/2000 | US6090365 Radioimmunotherapy of lymphoma using anti-CD20 antibodies |
| 07/18/2000 | US6090347 At least one blister includes an elongate container having an s-shaped part and a rinsing part connected to the elongate container by the s-shaped part, the elongate container and the rinsing part together functioning as a siphon. |
| 07/18/2000 | US6090268 Impressing voltages on electrodes in contact with the gas to obtain a change of hydrogen ionization current corresponding to carbon monoxide adsorption by the detection electrode; change in hydrogen ionization current as measure |
| 07/18/2000 | US6089079 Moisture sensor for ore concentrates and other perticulate materials |
| 07/18/2000 | CA2177603C Protecting nucleic acids and methods of analysis |
| 07/18/2000 | CA2170402C Novel disposable electronic assay device |
| 07/18/2000 | CA2144422C Continuous elemental analysis of process flows |
| 07/18/2000 | CA2093927C Ligand-mediated immunofunctional hormone binding protein assay method |
| 07/18/2000 | CA2069957C Chemiluminescent 3-(substituted adamant-2'-ylidene) 1,2-dioxetanes |
| 07/18/2000 | CA2025901C Solid phase analytical test device |
| 07/18/2000 | CA2011031C Plasmodium merozoite rhoptries antigen and derivatives thereof |
| 07/18/2000 | CA1341053C Polypeptide and protein derivatives and process for their preparation |
| 07/13/2000 | WO2000040988A1 Nmr spectroscopic in vitro assay using hyperpolarization |
| 07/13/2000 | WO2000040974A1 Pyridinium crosslinks assay |
| 07/13/2000 | WO2000040973A1 Assay for homocysteine |
| 07/13/2000 | WO2000040972A1 Nmr spectroscopy method |
| 07/13/2000 | WO2000040971A1 Pyk2 (raftk) and inflammation |
| 07/13/2000 | WO2000040970A1 Detecting and monitoring hiv viral infections |
| 07/13/2000 | WO2000040969A1 Method for the cellular high-throughput-detection of receptor ligand interactions |
| 07/13/2000 | WO2000040968A1 Binding of antibody fragments to solid supports |
| 07/13/2000 | WO2000040967A2 Method and device for diagnosing allergy symptoms |
| 07/13/2000 | WO2000040966A1 Method and kit for extracting prion protein |
| 07/13/2000 | WO2000040965A1 Fxr receptor-mediated modulation of cholesterol metabolism |
| 07/13/2000 | WO2000040964A1 Inhibition of cd4-ccr5 interaction |
| 07/13/2000 | WO2000040963A1 Method for determining platelet inhibitor response |
| 07/13/2000 | WO2000040956A1 Correcting protein induced error in ph-sensitive ise comprising a polymeric membrane |